| Dermatology and Skin Diseases | Lifetime | 33 | IT 1 | 99.74 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 21 | IT 1 | 99.68 |
| Autoimmune Bullous Skin Diseases | Lifetime | 51 | IT 3 | 99.32 |
| Immunotherapy and Immune Responses | Lifetime | 313 | IT 11 | 99.46 |
| Urticaria and Related Conditions | Lifetime | 66 | IT 7 | 99.14 |
| Allergic Rhinitis and Sensitization | Lifetime | 238 | IT 9 | 98.98 |
| Asthma and respiratory diseases | Lifetime | 563 | IT 21 | 98.70 |
| T-cell and B-cell Immunology | Lifetime | 687 | IT 15 | 98.76 |
| Spondyloarthritis Studies and Treatments | Lifetime | 127 | IT 12 | 98.55 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 421 | IT 36 | 97.36 |
| Biosimilars and Bioanalytical Methods | Lifetime | 227 | IT 14 | 96.01 |
| Food Allergy and Anaphylaxis Research | Lifetime | 466 | IT 26 | 96.93 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 410 | IT 37 | 96.28 |
| Retinoids in leukemia and cellular processes | Lifetime | 629 | IT 38 | 95.37 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 966 | IT 64 | 96.52 |
| Contact Dermatitis and Allergies | Lifetime | 555 | IT 35 | 95.76 |
| Pharmaceutical studies and practices | Lifetime | 859 | IT 24 | 94.91 |
| Autoimmune and Inflammatory Disorders | Lifetime | 367 | IT 29 | 94.87 |
| Nail Diseases and Treatments | Lifetime | 697 | IT 41 | 95.18 |
| Mast cells and histamine | Lifetime | 787 | IT 43 | 93.71 |
| Dermatological and Skeletal Disorders | Lifetime | 356 | IT 26 | 93.64 |
| Skin Diseases and Diabetes | Lifetime | 270 | IT 19 | 92.38 |
| Pregnancy and Medication Impact | Lifetime | 908 | IT 34 | 92.43 |
| Genetic and rare skin diseases. | Lifetime | 378 | IT 32 | 92.49 |
| Dermatological and COVID-19 studies | Lifetime | 259 | IT 31 | 89.13 |
| Therapeutic Uses of Natural Elements | Lifetime | 708 | IT 68 | 81.06 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 664 | IT 81 | 73.22 |
| Dermatology and Skin Diseases | 2021-2025 | 54 | IT 8 | 99.20 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 42 | IT 6 | 99.02 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 65 | IT 6 | 98.92 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 70 | IT 6 | 95.48 |
| Asthma and respiratory diseases | 2021-2025 | 343 | IT 51 | 96.91 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 111 | IT 23 | 96.08 |
| Urticaria and Related Conditions | 2021-2025 | 130 | IT 10 | 94.45 |
| Food Allergy and Anaphylaxis Research | 2021-2025 | 203 | IT 15 | 94.65 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 194 | IT 27 | 94.30 |
| Pharmaceutical studies and practices | 2021-2025 | 242 | IT 12 | 88.44 |
| Dermatological and Skeletal Disorders | 2021-2025 | 140 | IT 28 | 77.93 |
| Drug-Induced Adverse Reactions | 2021-2025 | 455 | IT 39 | 78.70 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 909 | IT 106 | 72.05 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 945 | IT 96 | 70.91 |
| Dermatological and COVID-19 studies | 2021-2025 | 317 | IT 72 | 68.54 |
| Skin and Cellular Biology Research | 2021-2025 | 401 | IT 19 | 68.84 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 947 | IT 96 | 68.19 |
| Contact Dermatitis and Allergies | 2021-2025 | 974 | IT 71 | 67.32 |
| Skin Diseases and Diabetes | 2021-2025 | 271 | IT 29 | 64.54 |
| Genetic and rare skin diseases. | 2021-2025 | 582 | IT 58 | 46.22 |
